AI-generated summary
The authors conducted a systematic review of clinical trials examining transcranial photobiomodulation for cognitive outcomes in traumatic brain injury, identifying six studies for full analysis. They report improvements in cognition for patients with chronic TBI after tPBM, with proposed mechanisms including changes in brain volume and blood flow. The authors note significant heterogeneity in application, no clear optimal parameters, and a lack of randomized controlled trials, so the finding is encouraging but uncertain.
- Studies included
- 6
- Who or what was studied
- Patients with traumatic brain injury, particularly chronic TBI
- Limits stated in the abstract
- The authors state there is significant heterogeneity in application, no determined optimal parameters, and a lack of randomized controlled trials in this field.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Introduction
Transcranial photobiomodulation (tPBM) is a non-invasive neuromodulation technology which has become a promising therapy for treating many brain diseases. Although it has been confirmed in studies targeting neurological diseases including Alzheimer's and Parkinson's that tPBM can improve cognitive function, the effectiveness of interventions targeting TBI patients remains to be determined. This systematic review examines the cognitive outcomes of clinical trials concerning tPBM in the treatment of traumatic brain injury (TBI).
Methods
We conducted a systematic literature review, following the PRISMA guidelines. The PubMed, Web of Science, Scopus, EMBASE, and Cochrane Library databases were searched before October 31, 2023.
Results
The initial search retrieved 131 articles, and a total of 6 studies were finally included for full text-analysis after applying inclusion and exclusion criteria.
Conclusion
Results showed improvements in cognition for patients with chronic TBI after tPBM intervention. The mechanism may be that tPBM increases the volume of total cortical gray matter (GM), subcortical GM, and thalamic, improves cerebral blood flow (CBF), functional connectivity (FC), and cerebral oxygenation, improving brain function. However, due to the significant heterogeneity in application, we cannot summarize the optimal parameters for tPBM treatment of TBI. In addition, there is currently a lack of RCT studies in this field. Therefore, given this encouraging but uncertain finding, it is necessary to conduct randomized controlled clinical trials to further determine the role of tPBM in cognitive rehabilitation of TBI patients.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Traumatic brain injury, Photobiomodulation, Systematic review, Cerebral blood flow, Randomized controlled trial, Neuromodulation, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.